SCHAUMBURG, Ill., Aug. 2 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced two FDA approvals -- sumatriptan succinate injection and ...

Zogenix to Present New Case Study Highlighting Successful Repositioning of Injectable Sumatriptan for Migraine With a Novel Needle-Free Delivery Technology Presentation at the 2nd Annual Drug ...

injectable sumatriptan market is expected to reach a considerably large market size in 2028 and register a high CAGR over the forecast period. NEW YORK, NY, UNITED STATES, March 10, 2022 /EINPresswire ...

(MENAFN- iCrowdNewsWire) As a part of the competitive landscape analysis, the report identifies the major competitors of the global Injectable Sumatriptan market along with their market share, company ...